Research Articles

In-depth guides, research summaries, and educational content for the scientific community.

Comprehensive peptide stability research guide covering degradation pathways and storage protocols

Peptide Stability: Complete Research Guide to Shelf Life, Storage, and Degradation

A comprehensive guide to peptide stability for researchers. Covers chemical and physical degradation pathways including oxidation, deamidation, hydrolysis, and aggregation. Explains how amino acid sequence, temperature, moisture, pH, and light affect shelf life. Provides evidence-based storage protocols for lyophilized and reconstituted peptides, quality verification strategies, and practical approaches to maximizing peptide integrity throughout the research workflow.

Mar 18, 2026 · 22 min read
Peptide Stability Peptide Storage Degradation
Peptide modifications and conjugates covering lipidation PEGylation disulfide bonds and research labeling

Peptide Modifications and Conjugates: Lipidation, PEGylation, and Beyond

A scientific guide to the chemical modifications used to enhance peptide stability, pharmacokinetics, and function. Covers lipidation (fatty acid conjugation for albumin binding — GLP-1 agonist peptide C-18, GLP dual agonist peptide C-20), PEGylation (polyethylene glycol attachment for half-life extension and reduced immunogenicity), disulfide bond formation and cyclization strategies, N-terminal and C-terminal capping (acetylation and amidation), non-natural amino acid incorporation (Aib for protease resistance, D-amino acids), fluorescent and biotin labeling for research applications, isotope labeling for quantitative proteomics, stapled peptides for helix stabilization, and how each modification is implemented during or after solid-phase peptide synthesis.

Mar 10, 2026 · 17 min read
Peptide Modification Lipidation PEGylation
Custom peptide synthesis considerations covering sequence specification purity grades and supplier evaluation

Custom Peptide Synthesis: What Researchers Need to Know

A practical guide for researchers ordering custom-synthesized peptides. Covers how to specify sequences correctly, selecting purity grades for different applications, cost factors, supplier evaluation, common specification mistakes, and documentation expectations.

Mar 10, 2026 · 14 min read
Custom Peptide Synthesis Purity Grade
Peptide purification methods showing HPLC chromatography separation from crude to research grade

Peptide Purification Methods: From Crude Synthesis to Research Grade

A scientific guide to the purification methods used to transform crude synthetic peptides into research-grade and pharmaceutical-grade products. Covers the nature of crude peptide impurities (deletion sequences, truncations, modification byproducts, diastereomers), reverse-phase HPLC as the primary purification method (C18 and C8 stationary phases, acetonitrile-water-TFA mobile phases, gradient optimization), preparative versus analytical HPLC, ion-exchange chromatography for charged peptides, size-exclusion chromatography for aggregate removal, the relationship between purity grades (crude, desalted, 95%, 98%, 99%) and research applications, yield and cost trade-offs, and quality verification through analytical HPLC and mass spectrometry.

Mar 10, 2026 · 16 min read
Peptide Purification HPLC Reverse Phase
Solid-phase peptide synthesis SPPS diagram showing Fmoc deprotection coupling and cleavage cycle

Solid-Phase Peptide Synthesis (SPPS): The Fmoc Method Explained

A detailed scientific explanation of Fmoc-based solid-phase peptide synthesis (SPPS) — the method used to manufacture virtually all modern research and therapeutic peptides. Covers the historical development from Merrifield's original Boc chemistry to the modern Fmoc/tBu strategy, the chemistry of each step in the synthesis cycle (resin loading, Fmoc deprotection via piperidine-mediated beta-elimination, amino acid activation and coupling, washing), the role of resins and linkers (Wang, Rink amide, 2-chlorotrityl), coupling reagent chemistry (HATU, DIC/OxymaPure, carbodiimides), common side reactions (aspartimide formation, racemization, deletion sequences, aggregation), monitoring methods (Kaiser test, UV absorbance), TFA cleavage cocktails and scavenger selection, automation and microwave-assisted synthesis, the recent wash-free SPPS breakthrough reducing solvent waste by 95%, and practical considerations for difficult sequences.

Mar 10, 2026 · 18 min read
SPPS Fmoc Solid Phase
Peptide synthesis and manufacturing guide covering SPPS Fmoc chemistry purification and lyophilization

Peptide Synthesis and Manufacturing: How Research Peptides Are Made

A comprehensive guide to how synthetic peptides are manufactured — from amino acid building blocks to purified, lyophilized research-grade products. Covers the fundamentals of solid-phase peptide synthesis (SPPS) including the Fmoc/tBu protecting group strategy, the iterative deprotection-coupling-washing cycle, resin chemistry and linker selection, coupling reagents (HATU, HBTU, DIC/OxymaPure), side-chain protection and orthogonality, TFA cleavage and global deprotection, crude peptide purification by preparative HPLC, quality control through analytical HPLC and mass spectrometry, lyophilization, disulfide bond formation, scale-up from research to GMP manufacturing, and the specific synthesis considerations for peptides like GLP-1 agonist peptide (lipidation), GLP dual agonist peptide (dual modifications), BPC-157, and AOD-9604 (disulfide cyclization).

Mar 10, 2026 · 20 min read
Peptide Synthesis SPPS Fmoc
AOD-9604 FDA GRAS regulatory history covering safety data clinical trials and legal classification

AOD-9604 FDA GRAS History and Regulatory Status

A factual analysis of AOD-9604's regulatory history, including its FDA GRAS (Generally Recognized As Safe) designation as a food ingredient, the distinction between GRAS status and drug approval, the clinical trial program that generated the safety data supporting the GRAS determination, the NOAEL findings from toxicology studies, the circumstances of pharmaceutical development termination in 2007, WADA prohibition status for competitive athletes, the current legal classification as a research chemical, and common misconceptions about what FDA GRAS means in practical and regulatory terms.

Mar 10, 2026 · 15 min read
AOD-9604 FDA GRAS
AOD-9604 stability and storage guide covering lyophilized handling reconstitution and degradation prevention

AOD-9604 Stability and Storage: Research Handling Guide

A practical scientific guide to the stability characteristics, storage requirements, and handling protocols for AOD-9604 in research settings. Covers the structural features that influence stability (disulfide bond, N-terminal tyrosine modification), degradation pathways including oxidation, hydrolysis, and aggregation, lyophilized storage conditions (-20°C long-term), reconstitution best practices with bacteriostatic water, reconstituted solution stability (2-8°C, approximately 28 days), visual indicators of degradation, the role of the disulfide bond in maintaining biological activity, and comparison with the stability profile of the unmodified hGH Fragment 176-191.

Mar 10, 2026 · 15 min read
AOD-9604 Stability Storage
AOD-9604 vs hGH Fragment 176-191 structural comparison showing tyrosine modification and differences

AOD-9604 vs hGH Fragment 176-191: Key Differences for Researchers

A scientific comparison of AOD-9604 and hGH Fragment 176-191 — two closely related but distinct peptides derived from the C-terminal region of human growth hormone. Covers the single amino acid difference (N-terminal tyrosine substitution for phenylalanine), how this modification affects stability, lipolytic potency, and research characterization, the shared core sequence and disulfide bond structure, why AOD-9604 was the compound advanced through clinical trials while the unmodified fragment was not, practical implications for research peptide selection, and how to verify identity through analytical methods.

Mar 10, 2026 · 12 min read
AOD-9604 hGH Fragment 176-191 Growth Hormone
AOD-9604 mechanism of action showing beta-3 adrenergic receptor lipolysis pathway in adipocytes

AOD-9604 Mechanism of Action: How the hGH Fragment Works

A detailed scientific analysis of how AOD-9604 exerts its metabolic effects at the molecular level. Covers the beta-3 adrenergic receptor upregulation pathway confirmed by knockout mouse studies, the cAMP-HSL-ATGL lipolytic cascade in adipocytes, simultaneous lipogenesis inhibition, the critical independence from GH receptor and JAK2-STAT5 signaling, absence of IGF-1 stimulation and diabetogenic effects, preferential action on obese versus lean adipocytes, emerging chondroprotective mechanisms in cartilage tissue, and comparison with the lipolytic mechanisms of full-length human growth hormone, GLP-1 receptor agonists, and ERR exercise mimetics.

Mar 10, 2026 · 16 min read
AOD-9604 Mechanism of Action Beta-3 Adrenergic
AOD-9604 research guide covering hGH fragment mechanism clinical trials and FDA GRAS status

AOD-9604: Complete Research Guide for Scientists

A comprehensive scientific guide to AOD-9604, the modified C-terminal fragment (amino acids 176-191) of human growth hormone with an N-terminal tyrosine substitution. Covers the discovery at Monash University by Professor Frank Ng, the beta-3 adrenergic receptor mechanism of lipolysis and lipogenesis inhibition, the critical distinction from full hGH (no IGF-1 stimulation, no diabetogenic effects, no GH receptor binding), the complete clinical trial history from Metabolic Pharmaceuticals (six human trials, 900+ subjects), the Phase IIb OPTIONS trial outcome, FDA GRAS status as a food ingredient, emerging cartilage repair and chondroprotective research, WADA prohibition status, practical handling and storage guidance, and context within the metabolic research peptide landscape.

Mar 10, 2026 · 21 min read
AOD-9604 hGH Fragment Growth Hormone
GLP-1 side effects science covering gastrointestinal tolerability pancreatitis thyroid and safety data

GLP-1 Side Effects: The Science Behind Safety and Tolerance

A scientific review of the adverse effect profile of GLP-1 receptor agonists. Covers the pharmacological mechanisms behind gastrointestinal side effects (nausea, vomiting, diarrhea, constipation), dose-titration strategies and tachyphylaxis, the pancreatitis question (FAERS signals vs RCT meta-analyses), gallbladder events and cholelithiasis risk from rapid weight loss, thyroid C-cell concerns (rodent data vs human evidence, FDA boxed warning context), perioperative aspiration risk and ASA guidance on gastric retention, muscle mass loss considerations, retinopathy signals, the January 2026 FDA removal of suicidal ideation warning, and how dual agonists like GLP dual agonist peptide may modulate GI tolerability through imbalanced receptor engagement.

Mar 10, 2026 · 18 min read
GLP-1 Side Effects Safety